Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (311-320 of 451) with videos related to

Pageof 46
Sort By:
Clinical Pharmacology and Therapeutics|January 12, 2017
QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac RepolarizationJ Keirns, A Desai, D Kowalski, et al.
Heart Rhythm|March 22, 2017
Acquired long QT syndrome in hospitalized patientsHaixu Yu, Li Zhang, Jinqiu Liu, et al.
Circulation|November 16, 2011
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE studyPeter R Kowey, Harry J G M Crijns, Etienne M Aliot, et al.
Diabetologia|August 6, 2005
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) studyG Boner, M E Cooper, K McCarroll, et al.
The New England Journal of Medicine|September 7, 2007
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterBramah N Singh, Stuart J Connolly, Harry J G M Crijns, et al.
Journal of Molecular and Cellular Cardiology|December 7, 2010
A novel mutation in the KCNH2 gene associated with short QT syndromeYaxun Sun, Xiao-Qing Quan, Samantha Fromme, et al.
International Journal of Cardiology. Heart & Vasculature|June 16, 2025
Antiarrhythmic drug use in atrial fibrillation among different European countries - as determined by a physician surveyEspen Fengsrud, Carina Blomström-Lundqvist, A John Camm, et al.
Heart Rhythm|October 26, 2024
An international physician survey of current ablation practices in atrial fibrillation: An AIM-AF substudySanjeev Saksena, April Slee, Jose L Merino, et al.
Circulation|December 1, 1995
Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators GroupP R Kowey, J H Levine, J M Herre, et al.
Circulation|December 1, 1995
Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators GroupM M Scheinman, J H Levine, D S Cannom, et al.
Pageof 46

Showing results (311-320 of 451) with videos related to

Sort By:
Pageof 46
Clinical Pharmacology and Therapeutics|January 12, 2017
QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac RepolarizationJ Keirns, A Desai, D Kowalski, et al.
Heart Rhythm|March 22, 2017
Acquired long QT syndrome in hospitalized patientsHaixu Yu, Li Zhang, Jinqiu Liu, et al.
Circulation|November 16, 2011
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE studyPeter R Kowey, Harry J G M Crijns, Etienne M Aliot, et al.
Diabetologia|August 6, 2005
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) studyG Boner, M E Cooper, K McCarroll, et al.
The New England Journal of Medicine|September 7, 2007
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterBramah N Singh, Stuart J Connolly, Harry J G M Crijns, et al.
Journal of Molecular and Cellular Cardiology|December 7, 2010
A novel mutation in the KCNH2 gene associated with short QT syndromeYaxun Sun, Xiao-Qing Quan, Samantha Fromme, et al.
International Journal of Cardiology. Heart & Vasculature|June 16, 2025
Antiarrhythmic drug use in atrial fibrillation among different European countries - as determined by a physician surveyEspen Fengsrud, Carina Blomström-Lundqvist, A John Camm, et al.
Heart Rhythm|October 26, 2024
An international physician survey of current ablation practices in atrial fibrillation: An AIM-AF substudySanjeev Saksena, April Slee, Jose L Merino, et al.
Circulation|December 1, 1995
Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators GroupP R Kowey, J H Levine, J M Herre, et al.
Circulation|December 1, 1995
Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators GroupM M Scheinman, J H Levine, D S Cannom, et al.
Pageof 46